Tamarack Advisers, LP Sanofi Transaction History

Tamarack Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$50.95 - $55.2 $3.31 Million - $3.59 Million	-65,000 Reduced 68.42%	30,000 $1.61 Million
Q1 2023 May 10, 2023	BUY	$45.86 - $54.45 $2.06 Million - $2.45 Million	45,000 Added 90.0%	95,000 $5.17 Million
Q4 2022 Feb 10, 2023	SELL	$38.86 - $48.55 $4.08 Million - $5.1 Million	-105,000 Reduced 67.74%	50,000 $2.42 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $2.23 Million - $6.03 Million	60,000 Added 63.16%	155,000 $5.89 Million
Q2 2022 Aug 16, 2022	BUY	$48.99 - $57.46 $4.65 Million - $5.46 Million	95,000 New	95,000 $4.75 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.